Prediction of gastrointestinal symptoms trajectories using omega-3 and inflammatory biomarkers in early-stage breast cancer patients receiving chemotherapy.
Daniela ArcosDing Quan NgYu KeYi Long TohAlexandre ChanPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2024)
Baseline IL-8 and DHA predicted GI symptom progression in early-stage breast cancer patients undergoing chemotherapy. Future studies are required to evaluate how therapeutic intervention targeting these biomarkers may mitigate gastrointestinal symptoms in cancer patients.
Keyphrases
- early stage
- patients undergoing
- locally advanced
- randomized controlled trial
- sentinel lymph node
- depressive symptoms
- sleep quality
- oxidative stress
- current status
- squamous cell carcinoma
- cancer therapy
- rectal cancer
- physical activity
- neoadjuvant chemotherapy
- case control
- breast cancer risk
- chemotherapy induced
- patient reported